Article Details
Retrieved on: 2021-11-30 16:12:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... to monitor lecanemab's efficacy and help determine dosages, data show. ... according to a new analysis of data from a Phase 2b clinical trial.
Article found on: alzheimersnewstoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here